Last reviewed · How we verify

NCT05360810

Wei Nasal Jet Tube vs Gastro Laryngeal Tube in Endoscopic Retrograde Cholangiopancreatography

Completed NA Last updated 15 September 2022
What this trial tests

NA trial testing Wei Nasal Jet Tube in Supraglottic Airway Efficiency in 114 participants. Completed in 15 August 2022.

Timeline
10 May 2022
Primary endpoint
1 August 2022
15 August 2022

Quick facts

Lead sponsorBezmialem Vakif University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposescreening
Enrollment114
Start date10 May 2022
Primary completion1 August 2022
Estimated completion15 August 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

Adults 18 to 70, any sex, with Supraglottic Airway Efficiency or Airway Complication of Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The most common adverse event in endoscopic procedures is hypoxia. Different airway devices have been investigated in the literature to prevent hypoxia. This study aimed to compare the efficacy and procedural performance of two different airway (GLT and WNJ) devices in ERCP procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Wei Nasal Jet Tube

Trials testing the same drug.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05360810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing